Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The implementation of an iPad application for colon cancer screening doubled the number of patients who underwent testing, according to a study published March 13 in the Annals of Internal Medicine.
Scientists from the University of Bath in the U.K. have developed a non-invasive, adhesive patch capable of accurately measuring glucose levels through the skin without a blood test, according to a study published April 9 in Nature Nanotechnology.
Omni MedSci, a healthcare technology startup, has filed a lawsuit against Apple claiming the company infringed four patents in developing the Apple Watch’s heart rate sensor.
HHS’s Office of the National Coordinator for Health Information Technology (ONC) has released an online guide for patients and caregivers to improve the utilization of patient portals and access to health information.
WebMD has redesigned its Symptom Checker tool, used by 75 million people every month, to improve usability and accuracy in providing users with an outline of most relevant clinical data to make informed health decisions.
In the past month, two studies came to very different conclusions when examining if the human brain is capable of growing new neurons later in life. The first, published March 7 in Nature, found no evidence of neurogenesis in individuals older than 13 years old. But another study, released April 5 in Cell Stem Cell, claimed to find neuron generation in all the brains examined.
As the baby boomer generation ages, more patients are seeking joint replacements. What could be a financial windfall for orthopedic surgeons and practices is beginning to become a problem as providers are struggling to keep up with the demand.
Headlining the National Rx Drug Abuse and Heroin Summit in Atlanta on April 4, FDA Commissioner Scott Gottlieb, MD, criticized internet providers in efforts to reduce illegal online sales of opioids such as fentanyl and heroin.
